Of the 68 patients that had died from COVID-19, 11 patients (16%) had a secondary infection (Wuhan, China).

Mortality in Secondary COVID-19 Infection in Wuhan, China

The distribution of survival time from disease onset to death showed two peaks, with the first one at approximately 14 days (22 cases) and the second one at approximately 22 days (17 cases).

Survival Times of Patients with COVID-19 in Wuhan, China

Among the 68 fatal cases, 36 patients (53%) died of respiratory failure, five patients (7%) with myocardial damage died of circulatory failure, 22 patients (33%) died of both, and five remaining died of an unknown cause.

Cause of Death in COVID-19 Patients in Wuhan, China

As of March 3, 2020, a study of 150 COVID-19-infected patients found a morbidity: 19% (p-value<0.001)

Cardiovascular Disease in COVID-19 Patients in Wuhan, China: Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China

University of Michigan - Ann Arbor

Epidemiological studies of COVID-19 in China can be classified by research focus, including transmission, communicable period, fatality, control strategies, secondary infections, patient comorbidities and outcomes, signs and symptoms, patient demographics, geographic region, and time from symptom onset to reporting.

Classification of Epidemiological Studies on COVID-19 in China by Research Focus

Classification of Studies on Transmission of COVID-19 in China

- Gender
- Age
- Race
- Ethnicity
- Marital status
- Income
- Education
- Employment

Learn Before

Related

Learn After